National Neuroscience Institute

This phase 2 trial is testing an oral drug called ACT001 in 12 adults whose glioblastoma has returned after standard treatment. The study focuses on patients whose tumors have a specific genetic signature (STAT3-high). Researchers will check if the drug can shrink or stabilize th…

This study looks at whether genetic testing can help doctors pick the right antiplatelet medicine for people who have had a stroke or mini-stroke. About 350 patients will be randomly assigned to either standard care or a genetic test that checks if a common drug, clopidogrel, is …

This study tests whether a daily dose of tocotrienols (a type of vitamin E) can slow the worsening of motor symptoms in Parkinson's disease. One hundred adults with Parkinson's will take either the supplement or a placebo for two years. Researchers will track movement, thinking, …